Hy-Vee recalled its ready-to-eat Spring Pasta Salad after reports of about 20 individuals in four states sickened after consuming the product. The salads were packed in plastic containers, which were distributed to Hy-Vee's 244 grocery stores in Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, South Dakota and Wisconsin.
Akcea Therapeutics and Ionis Pharmaceuticals' Tegsedi, or inotersen, was approved by European regulators as a treatment for patients with the rare disease hereditary transthyretin amyloidosis, allowing doctors to prescribe it to patients with the disease who have stage I or II polyneuropathy.
Nohla Therapeutics' dilanubicel, being developed to reduce morbidity and mortality associated with hematopoietic stem cell transplant, was given the FDA's orphan drug designation. The decision was backed by data from a midstage trial, in which treatment with dilanubicel led to a faster neutrophil and platelet recovery versus the control group, and infusion of the drug did not cause severe acute graft-versus-host disease or transplant-linked mortality.
European regulators have granted Lumendi approval for its single-use DiLumen Endolumenal Interventional Platform device, which facilitates visualization, diagnosis and treatment of large intestine conditions by providing endoscopic stability.
Nova Biomedical was given 510(k) clearance by the FDA for StatStrip, a finger-stick capillary testing glucose meter, for critically ill patients with and without diabetes. The clearance was granted after studies showed the device's safety, efficacy and reliability.
EpiBiome's high-throughput bacteriophage discovery platform was purchased by CRISPR-Cas3-engineered precision antibacterial products developer Locus Biosciences for an undisclosed amount. The deal will help Locus develop CRISPR-engineered phage antibiotic-resistant bacterial infection therapies.
The Sickle Cell Foundation of Georgia, Biotech Research Laboratories and the Phoenix Tears Foundation aim to raise $250,000 to advance an early-stage study to evaluate the safety and efficacy of medical cannabis oil to manage pain in sickle cell disease patients. Pain management is one way to improve the quality of life of SCD patients.
Modern farming techniques such as plant biotechnology will help in meeting the global demand of producing 70% more food by 2050, writes Queensland Farmers' Federation President Stuart Armitage. Governments must ensure that unnecessary regulations do not prevent farmers from reaping the food supply and security benefits of biotech crops, he writes.
- Page 1